Fighting the resistance: Antibiotics in the modern world

Antimicrobial agents are the workhorse of modern medicine; diseases and infections once considered a death sentence are now routinely mitigated by antibacterial drugs and treatments on a daily basis. However, as their continued uses forces evolutionary pressure onto the targeted microbes, antibacterial agents are creating drug-resist pathogens at an estimated cost of 700,000 lives annually, and growing economic cost projected to total over $100 trillion by 2050 (O’Neill, et al., 2014).

How will biotechnology address this rising tide of antibiotic resistant bacteria and what new treatments and philosophies will we develop in our war against the microbes? Come discuss the current state and future of antibiotic resistance with HiveBio this Wednesday, April 15th at 7:30 PM in Ada’s Technical Books (425 15th Ave E).